These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 17162099)
1. Re: A systematic review of vitamin D receptor gene polymorphisms and prostate cancer risk. S. I. Berndt, J. L. Dodson, W. Y. Huang and K. K. Nicodemus, J Urol 2006; 175: 1613-1623. Rukin NJ; Luscombe CJ; Strange RC J Urol; 2007 Jan; 177(1):404. PubMed ID: 17162099 [No Abstract] [Full Text] [Related]
2. [Association of vitamin D receptor gene polymorphism with prostate cancer]. Hamasaki T; Inatomi H; Matsumoto T; Katoh T Nihon Rinsho; 2002 Dec; 60 Suppl 11():465-8. PubMed ID: 12599620 [No Abstract] [Full Text] [Related]
3. Association between polymorphisms of the androgen and vitamin D receptor genes with prostate cancer risk in a Mexican population. Patiño-García B; Arroyo C; Rangel-Villalobos H; Soto-Vega E; Velarde-Félix JS; Gabilondo F; Sandoval-Ramirez L; Figuera LE Rev Invest Clin; 2007; 59(1):25-31. PubMed ID: 17569297 [TBL] [Abstract][Full Text] [Related]
4. Re: Genetic polymorphisms of matrix metalloproteinases: susceptibility and prognostic implications for prostate cancer. S. T. dos Reis, J. Pontes, Jr., F. E. Villanova, P. M. D. Borra, A. A. Antunes, M. F. Dall'oglio, M. Srougi and K. R. M. Leite. J Urol 2009; 181: 2320-2325. Ahirwar DK; Mittal RD J Urol; 2010 Mar; 183(3):1258. PubMed ID: 20097381 [No Abstract] [Full Text] [Related]
5. Association of genetic polymorphisms in vitamin D receptor gene and susceptibility to sporadic prostate cancer. Onen IH; Ekmekci A; Eroglu M; Konac E; Yesil S; Biri H Exp Biol Med (Maywood); 2008 Dec; 233(12):1608-14. PubMed ID: 18849534 [TBL] [Abstract][Full Text] [Related]
6. Correspondence re: J.L. Stanford et al., Polymorphic receptor in the androgen receptor gene: molecular markers of prostate cancer risk. Cancer Res., 57: 1194-1198, 1997. Yasui T Cancer Res; 2000 Jan; 60(2):499. PubMed ID: 10667606 [No Abstract] [Full Text] [Related]
7. Vitamin D receptor genotypes/haplotypes and prostate cancer risk. Cicek MS; Liu X; Schumacher FR; Casey G; Witte JS Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2549-52. PubMed ID: 17164384 [TBL] [Abstract][Full Text] [Related]
8. Re: Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. K. Eichler, S. Hempel, J. Wilby, L. Myers, L. M. Bachmann and J. Kleijnen, J Urol, 175: 1605-1612, 2006. Eskicorapci SY; Tuncay L J Urol; 2006 Dec; 176(6 Pt 1):2745; author reply 2745-6. PubMed ID: 17085209 [No Abstract] [Full Text] [Related]
9. Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk. Raimondi S; Johansson H; Maisonneuve P; Gandini S Carcinogenesis; 2009 Jul; 30(7):1170-80. PubMed ID: 19403841 [TBL] [Abstract][Full Text] [Related]
10. [Vitamin D and cancer]. Yamana K; Saito H; Takenouchi K; Azuma Y; Ishizuka S Clin Calcium; 2006 Jul; 16(7):1147-53. PubMed ID: 16816475 [TBL] [Abstract][Full Text] [Related]
11. Re: Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection. S. J. Freedland, E. A. Platz, J. C. Presti Jr., W. J. Aronson, C. L. Amling, C. J. Kane and M. K. Terris. J Urol, 175: 500-504, 2006. Stamatiou K; Alevizos A; Mariolis A; Sofras F J Urol; 2006 Sep; 176(3):1251-2; author reply 1252. PubMed ID: 16890735 [No Abstract] [Full Text] [Related]
12. Re: Prediagnosis prostate specific antigen velocity is associated with risk of prostate cancer progression following brachytherapy and external beam radiation therapy. S. E. Eggener, K. A. Roehl, O. Yossepowitch and W. J. Catalona, J Urol 2006; 176: 1399-1403. Wagner MD; Daneshmand S; Sokoloff M; Barry JM J Urol; 2007 Jun; 177(6):2396; author reply 2396-7. PubMed ID: 17509368 [No Abstract] [Full Text] [Related]
13. Vitamin D receptor gene polymorphisms are associated with increased risk and progression of renal cell carcinoma in a Japanese population. Obara W; Suzuki Y; Kato K; Tanji S; Konda R; Fujioka T Int J Urol; 2007 Jun; 14(6):483-7. PubMed ID: 17593089 [TBL] [Abstract][Full Text] [Related]
14. Can diet and/or sunlight modify the relationship between vitamin D receptor polymorphisms and prostate cancer risk? Ingles SA Nutr Rev; 2007 Aug; 65(8 Pt 2):S105-7. PubMed ID: 17867382 [No Abstract] [Full Text] [Related]
15. Vitamin D and tuberculosis. Chocano-Bedoya P; Ronnenberg AG Nutr Rev; 2009 May; 67(5):289-93. PubMed ID: 19386033 [TBL] [Abstract][Full Text] [Related]
16. Re: A multi-institutional evaluation of active surveillance for low risk prostate cancer. S. E. Eggener, A. Mueller, R. K. Berglund, R. Ayyathurai, C. Soloway, M. S. Soloway, R. Abouassaly, E. A. Klein, S. J. Jones, C. Zappavigna, L. Goldenberg, P. T. Scardino, J. A. Eastham and B. Guillonneau J Urol 2009; 181: 1635-1641. Ayres BE; Bott SR; Barber NJ; Langley SE; Montgomery BS J Urol; 2010 Sep; 184(3):1223-4; author reply 1224. PubMed ID: 20655069 [No Abstract] [Full Text] [Related]
17. Androgen and vitamin D receptor gene polymorphisms: the long and short of prostate cancer risk. Feldman D J Natl Cancer Inst; 1997 Jan; 89(2):109-11. PubMed ID: 8998174 [No Abstract] [Full Text] [Related]
18. Vitamin D receptor gene polymorphisms in Turkish children with vitamin D deficient rickets. Bora G; Ozkan B; Dayangaç-Erden D; Erdem-Yurter H; Coşkun T Turk J Pediatr; 2008; 50(1):30-3. PubMed ID: 18365588 [TBL] [Abstract][Full Text] [Related]
19. Vitamin D receptor gene polymorphisms and epithelial ovarian cancer risk. Lurie G; Wilkens LR; Thompson PJ; McDuffie KE; Carney ME; Terada KY; Goodman MT Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2566-71. PubMed ID: 18086759 [TBL] [Abstract][Full Text] [Related]
20. Re: Prostate cancer severity among low income, uninsured men. D. C. Miller, M. S. Litwin, J. Bergman, S. Stepanian, S. E. Connor, L. Kwan and W. J. Aronson. J Urol 2009; 181: 579-584. Watson RA J Urol; 2010 Mar; 183(3):1259-60; author reply 1260. PubMed ID: 20097378 [No Abstract] [Full Text] [Related] [Next] [New Search]